Long-term melatonin administration enhances the antioxidant potential of human plasma maintained after discontinuation of the treatment

General Physiology and Biophysics

Volumn 29, Issue 2, 2010, Pages 144-150

  Piechota, Aleksandra ^a   Lipińska, Stanisława ^a   Szemraj, Janusz ^a   Gora̧ca, Anna ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Antioxidant activity; Free radical; Melatonin; Oxidative stress

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; DNA; MELATONIN; RADICAL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; 2,2-DIPHENYL-1-PICRYLHYDRAZYL; ANTIOXIDANT; BIPHENYL DERIVATIVE; PICRIC ACID; SCAVENGER;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DNA DAMAGE; FOLLOW UP; HORMONE ACTION; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PINEAL BODY; PLASMA; TREATMENT DURATION; BLOOD; CASE CONTROL STUDY; DRUG ADMINISTRATION; DRUG EFFECTS; IN VITRO STUDY; LIPID PEROXIDATION; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; OXIDATIVE STRESS; YOUNG ADULT;

ADMINISTRATION, ORAL; ADULT; ANTIOXIDANTS; BIPHENYL COMPOUNDS; CASE-CONTROL STUDIES; DNA DAMAGE; DRUG ADMINISTRATION SCHEDULE; FREE RADICAL SCAVENGERS; HUMANS; IN VITRO TECHNIQUES; LIPID PEROXIDATION; MELATONIN; MIDDLE AGED; OXIDATIVE STRESS; PICRATES; THIOBARBITURIC ACID REACTIVE SUBSTANCES; YOUNG ADULT;

EID: 77954139625     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: 10.4149/gpb_2010_02_144     Document Type: Article

References (36)

1. Andreadou I., Tsantili-Kakoulidou A., Spyropoulou E., Siatra T. (2003): Reactions of indole derivatives with cardioprotective activity with reactive oxygen species. Comparison with melatonin. Chem. Pharm. Bull. (Tokyo) 51, 1128- 1131; doi:10.1248/cpb.51.1128
2. Aydogan S., Yerer M. B., Goktas A. (2006): Melatonin and nitric oxide. J. Endocrinol. Invest. 29, 281-287
3. Benzie I. F., Strain J. J. (1996): The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal. Biochem. 239, 70-76; doi:10.1006/ abio.1996.0292
4. Chan T. Y., Tang P. L. (1996): Characterization of the antioxidant effects of melatonin and related indoleamines in vitro. J. Pineal. Res. 20, 187-191; doi:10.1111/j.1600-079X.1996. tb00257.x
5. Chrzczanowicz J., Gawron A., Zwolinska A., de Graft-Johnson J., Krajewski W., Krol M., Markowski J., Kostka T., Nowak D. (2008): Simple method for determining human serum 2,2-diphenyl-1-picryl-hydrazyl (DPPH) radical scavenging activity - possible application in clinical studies on dietary antioxidants. Clin. Chem. Lab. Med. 46, 342-349; doi:10.1515/CCLM.2008.062
6. Djeridane Y., Pitrosky B., Viven-Roels B., Simonneaux V., Kirsch R., Pévet P. (2000): Long-term daily melatonin infusion induces a large increase in N-acetyltransferase activity, hydroxyindole-O-methyltransferase activity, and melatonin content in the Harderian gland and eye of pinealectomized male Siberian hamsters (Phodopus syngorus). J. Pineal. Res. 29, 65-73; doi:10.1034/j.1600- 079X.2000.290201.x
7. Goraca A., Cieśla W. (2006): The role of melatonin in lipid peroxidation in healthy subjects. Pol. Merkur. Lekarski 21, 59-61 (in Polish)
8. Halliwell B., Gutteridge J. M. (1990): The antioxidants of human extracellular fluids. Arch. Biochem. Biophys. 280, 1-8; doi:10.1016/0003- 9861(90)90510-6
9. Hardeland R., Pandi-Perumal S. R. (2005): Melatonin, a potent agent in antioxidative defense: Actions as a natural food constituent, gastrointestinal factor, drug and prodrug. Nutr. Metab. 2, 22; doi:10.1186/1743-7075-2-22
10. Herrera J., Nava M., Romero F., Rodríguez-Iturbe B. (2001): Melatonin prevents oxidative stress resulting from iron and erythropoietin administration. Am. J. Kidney Dis. 37, 750-757; doi:10.1016/S0272-6386(01)80124- 4
11. Ianas O., Olinescu R., Badescu I. (1991): Melatonin involvement in oxidative stress. Endocrinologie 29, 147-153
12. Jaworek J., Nawrot-Porabka K., Leja-Szpak A., Bonior J., Szklarczyk J., Kot M., Konturek S. J., Pawlik W. W. (2007): Melatonin as modulator of pancreatic enzyme secretion and pancreatoprotector. J. Physiol. Pharmacol. 58, 65-80
13. Jimenez-Jorge S., Guerrero J. M., Jimenez-Caliani A. J., Naranjo M. C., Lardone P. J., Carrillo-Vico A., Osuna C., Molinero P. (2007): Evidence for melatonin synthesis in the rat brain during development. J. Pineal. Res. 42, 240-246; doi:10.1111/j.1600-079X.2006.00411.x
14. Jou M. J., Peng T. I., Yu P. Z., Jou S. B., Reiter R. J., Chen J. Y., Wu H. Y., Chen C. C., Hsu L. F. (2007): Melatonin protects against common deletion of mitochondrial DNA-augmented mitochondrial oxidative stress and apoptosis. J. Pineal. Res. 43, 389-403; doi:10.1111/ j.1600-079X.2007.00490.x
15. Karasek M., Winczyk K. (2006): Melatonin in humans. J. Physiol. Pharmcol. 57, 19-39
16. Karbownik M., Reiter R. J., Qi W., Garcia J. J., Tan D. X., Manchester L. C., Vijayalaxmi (2000): Protective effects of melatonin against oxidation of guanine bases in DNA and decreased microsomal membrane fluidity in rat liver induced by whole body ionizing radiation. Mol. Cell. Biochem. 211, 137-144; doi:10.1023/A:1007148530845
17. Kawanishi S., Murata M. (2006): Mechanism of DNA damage induced by bromate differs from general types of oxidative stress. Toxicology 221, 172-178; doi:10.1016/ j.tox.2006.01.002
18. Kedziora-Kornatowska K., Szewczyk-Golec K., Czuczejko J., Pawluk H., van Marke de Lumen K., Kozakiewicz M., Bartosz G, Kedziora J. (2008): Antioxidative effects of melatonin administration in elderly primary essential hypertension patients. J. Pineal Res. 45, 312-317; doi:10.1111/j.1600- 079X.2008.00592.x
19. Kedziora-Kornatowska K., Szewczyk-Golec K., Kozakiewicz M., Pawluk H., Czuczejko J., Kornatowski T., Bartosz G., Kedziora J. (2009): Melatonin improves oxidative stress parameters measured in the blood of elderly type 2 diabetic patients. J. Pineal Res. 46, 333-337; doi:10.1111/ j.1600-079X.2009.00666.x
20. Kimball S. R., Abbas A., Jefferson L. S. (2008): Melatonin represses oxidative stress-induced activation of the MAP kinase and mTOR signaling pathways in H4IIE hepatoma cells through inhibition of Ras. J. Pineal Res. 44, 379-386; doi:10.1111/j.1600-079X.2007.00539.x (Pubitemid 351545739)
21. Konturek S. J., Konturek P. C., Brzozowska I., Pawlik M., Sliwowski Z., Cześnikiewicz-Guzik M., Kwiecień S., Brzozowski T., Bubenik G. A., Pawlik W. W. (2007): Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT). J. Physiol. Pharmacol. 58, 381-405
22. Lisitsa G. V., Zaslavskaia R. M., Kalinina E. V. (2005): Effectiveness of metabolic preparations in complex treatment of elderly patients with postinfarction cardiosclerosis and circulatory insufficiency. Klin. Med. (Mosk.) 83, 54-57 (in Russian)
23. Martín M., Marcías M., Escames G., León J., Acuña-Castroviejo D. (2000): Melatonin but not vitamins C and E maintain glutathione homeostasis in t-butyl hydroperoxide- induced mitochondrial oxidative stress. FASEB J. 14, 1677-1679
24. Mozdzan M., Szemraj J., Rysz J., Nowak D. (2005): Antioxidant properties of carnosine re-evaluated with oxidizing system involving iron and copper ions. Basic. Clin. Pharmacol. Toxicol. 96, 352-360; doi:10.1111/j.1742- 7843.2005.pto-03.x
25. Muñoz-Casares F. C., Padillo F. J., Briceño J., Collado J. A., Muñoz- Castaneda J. R., Ortega R., Cruz A., Túnez I., Montilla P., Pera C., Muntané J. (2006): Melatonin reduces apoptosis and necrosis induced by ischemia/reperfusion injury of the pancreas. J. Pineal. Res. 40, 195-203; doi:10.1111/ j.1600-079X.2005.00291.x
26. Reiter R. J., Tan D. X., Cabrera J., D'Arpa D., Sainz R. M., Mayo J. C., Ramos S. (1999): The oxidant/antioxidant network: role of melatonin. Biol. Signals Recept. 8, 56-63; doi:10.1159/000014569
27. Reiter R. J., Tan D. X., Manchester L. C., Lopez-Burillo S., Sainz R. M., Mayo J. C. (2003): Melatonin: detoxification of oxygen and nitrogen-based toxic reactants. Adv. Exp. Med. Biol. 527, 539-548
28. Simonneaux V., Ribelayga C. (2003): Generation of the melatonin endocrine message in mammals: a review of the complex regulation of melatonin synthesis by norepinephrine, peptides and other pineal transmitters. Pharmacol. Rev. 55, 325-395; doi:10.1124/pr.55.2.2
29. Sliwinski T., Rozej W., Morawiec-Bajda A., Morawiec Z., Reiter R., Blasiak J. (2007): Protective action of melatonin against oxidative DNA damage: chemical inactivation versus base-excision repair. Mutat. Res. 634, 220-227
30. Subramanian P., Mirunalini S., Pandi-Perumal S. R., Trakht I., Cardinali D. P. (2007): Melatonin treatment improves the antioxidant status and decreases lipid content in brain and liver of rats. Eur. J. Pharmacol. 571, 116-119; doi:10.1016/j.ejphar.2007.06.011
31. Tan D. X., Manchester L. C., Reiter R. J., Plummer B. F., Limson J., Weintraub S. T., Qi W. (2000): Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation. Free Radic. Biol. Med. 29, 1177-1185; doi:10.1016/S0891-5849(00)00435-4
32. Teixeira A., Morfim M. P., de Cordova G. A., Charao C. C., de Lima V. R., Creczynski-Pasa T. B. (2003): Melatonin protects against pro-oxidant enzymes and reduces lipid peroxidation in distinct membranes induced by the hydroxyl and ascorbyl radicals and by peroxynitrite. J. Pineal Res. 35, 262-268; doi:10.1034/j.1600- 079X.2003.00085.x
33. Tubaro F., Ghiselli A., Rapuzzi P., Maiorino M., Ursini F. (1998): Analysis of plasma antioxidant capacity by competition kinetics. Free Radic. Biol. Med. 24, 1228-1234; doi:10.1016/S0891-5849(97)00436-X
34. Valko M., Rhodes C. J., Moncol J., Izakovic M., Mazur M. (2006): Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 160, 1-40; doi:10.1016/j.cbi.2005.12.009
35. Wakatsuki A., Okatani Y., Ikenoue N., Izumiya C., Kaneda C. (2000): Melatonin inhibits oxidative modification of low-density lipoprotein particles in normolipidemic post-menopausal women. J. Pineal Res. 28, 136-142
36. Zhao F., Liu Z. Q., Wu D. (2008): Antioxidative effect of melatonin on DNA and erythrocytes against free-radical-induced oxidation. Chem. Phys. Lipids 151, 77-84; doi:10.1016/ j.chemphyslip.2007.10.002